CYP1A1与CYP3A5基因多态性影响孕吐孕妇格拉司琼清除与暴露的变异性
本研究纳入16名孕12-19周伴恶心呕吐的孕妇,单次给予格拉司琼1 mg后分析CYP3A4、CYP3A5、CYP1A1和ABCB1基因多态性对药代动力学的影响。结果显示CYP3A5*3纯合子清除率显著降低、AUC升高,CYP1A1*2A携带者清除率显著升高、AUC降低。
要点
- CYP3A5*3纯合孕妇格拉司琼清除率显著降低、AUC升高。
- CYP1A1*2A携带孕妇格拉司琼清除率显著升高、AUC降低。
- CYP3A4和ABCB1基因多态性未显示对格拉司琼AUC或清除率有显著影响。
核心结论
- CYP3A5和CYP1A1基因多态性可部分解释妊娠期格拉司琼全身清除率和暴露的个体间变异。
研究设计与样本
- 研究纳入16名孕12-19周伴恶心呕吐的孕妇,均接受格拉司琼1 mg治疗。
- 采用液相色谱串联质谱法测定格拉司琼血浆浓度,TaqMan SNP基因分型法测定基因型。
- 以静脉格拉司琼清除率作为因变量分析基因多态性与药代动力学的关联。
主要发现
- 16名患者中25%为CYP3A5*3等位基因纯合子,其格拉司琼清除率显著低于非纯合患者,AUC显著升高。
- 约三分之一患者(n=5)为CYP1A1*2A等位基因携带者,其格拉司琼清除率显著高于非携带者,AUC显著降低。
- CYP3A4和ABCB1基因任何SNP对格拉司琼AUC或清除率均未发现显著差异。
临床怎么用
- 对孕吐孕妇使用格拉司琼时,可关注CYP3A5*3和CYP1A1*2A基因型,以辅助预判药物暴露差异。
局限性
- 研究样本量较小(16例),结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nausea and vomiting affect up to 90% of pregnant women. Granisetron is a potent and highly selective serotonin receptor antagonist and is an effective antiemetic. Findings from a prior study in pregnant women demonstrated a large interindividual variability in granisetron exposure. Granisetron is primarily metabolized by the cytochrome P450 (CYP) enzymes CYP1A1 and CYP3A and is likely a substrate of the ABCB1 transporter. Single-nucleotide polymorphisms (SNPs) in CYP3A, CYP1A1, and ABCB1 can alter drug metabolism. OBJECTIVE: This study evaluated the influence of polymorphisms in CYP3A4, CYP3A5, CYP1A1, and ABCB1 on the pharmacokinetic properties of granisetron in pregnant women. METHODS: The study enrolled 16 pregnant women (gestational age of 12-19 wks). All patients had nausea and vomiting and were treated with granisetron 1 mg. Granisetron plasma concentrations were determined using liquid chromatography tandem-mass spectrometry. The patients' genotype was determined using TaqMan SNP Genotyping Assays. The Hardy-Weinberg equilibrium was assessed by comparing observed and expected genotype frequencies, using the exact test. Intravenous granisetron clearance was used as the dependent variable for analysis of associations. RESULTS: Of 16 patients, 25% were homozygous for the allele variant CYP3A5*3 and had a significantly lower granisetron clearance and increased area under the plasma concentration-versus-time curve (AUC) compared with nonhomozygous patients. Approximately one-third of patients (n=5) were carriers for the allele variant CYP1A1*2A and had a significantly higher granisetron clearance and decreased AUC. We did not find significant differences in the AUC or clearance for any SNPs in CYP3A4 and ABCB1 genes. CONCLUSIONS: Polymorphisms in CYP3A5 and CYP1A1 account for some of the variability in systemic clearance and exposure of granisetron in pregnant women.
引用
- Bustos ML, Zhao Y, Chen H, et al. Polymorphisms in CYP1A1 and CYP3A5 Genes Contribute to the Variability in Granisetron Clearance and Exposure in Pregnant Women with Nausea and Vomiting. Pharmacotherapy. 2016. PMID: 27809336. doi:10.1002/phar.1860
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。